Corteva (NYSE:CTVA) Hits New 12-Month High – Here’s What Happened

Corteva, Inc. (NYSE:CTVA)’s share price hit a new 52-week high on Friday . The stock traded as high as $87.89 and last traded at $87.8060, with a volume of 269353 shares traded. The stock had previously closed at $86.65.

Analyst Ratings Changes

CTVA has been the topic of a number of research analyst reports. Mizuho lifted their target price on Corteva from $96.00 to $97.00 and gave the company an “outperform” rating in a research report on Tuesday. BNP Paribas Exane increased their price target on Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. Argus raised their price objective on Corteva from $80.00 to $91.00 and gave the stock a “buy” rating in a research report on Tuesday, March 31st. Weiss Ratings upgraded shares of Corteva from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, May 7th. Finally, Citigroup upped their target price on shares of Corteva from $83.00 to $85.00 and gave the company a “neutral” rating in a research report on Thursday, May 7th. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $88.95.

Corteva Trading Up 1.6%

The company has a 50 day moving average of $80.74 and a 200-day moving average of $78.13. The stock has a market cap of $58.87 billion, a price-to-earnings ratio of 51.56, a price-to-earnings-growth ratio of 2.58 and a beta of 0.56. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47.

Corteva (NYSE:CTVA) last released its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, beating the consensus estimate of $1.18 by $0.32. The company had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.Corteva’s revenue was up 11.0% compared to the same quarter last year. During the same period in the previous year, the company posted $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, research analysts anticipate that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were issued a $0.18 dividend. The ex-dividend date was Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.8%. Corteva’s payout ratio is 42.35%.

Institutional Investors Weigh In On Corteva

A number of hedge funds have recently added to or reduced their stakes in the business. Drummond Knight Asset Management Pty Ltd acquired a new stake in Corteva in the fourth quarter valued at approximately $25,713,000. Arbejdsmarkedets Tillaegspension acquired a new position in Corteva during the 4th quarter worth approximately $23,679,000. Avior Wealth Management LLC grew its holdings in Corteva by 464.7% during the 4th quarter. Avior Wealth Management LLC now owns 32,901 shares of the company’s stock worth $2,205,000 after acquiring an additional 27,075 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. increased its position in shares of Corteva by 23.5% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 110,075 shares of the company’s stock valued at $7,378,000 after purchasing an additional 20,957 shares during the last quarter. Finally, Leonteq Securities AG acquired a new stake in shares of Corteva in the 4th quarter valued at $2,350,000. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.